National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
In English | En español
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
 Display for Print  New Search
 
Results: 1 -7 of 7         results per page
 View Search Criteria | Help With Results
           
Last Modified: 7/11/2007     First Published: 4/13/2007  

1.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Biomarker/Laboratory analysis, Treatment
Active
18 and over
NCI
UCIRVINE-UCI03-1-01
UCI03-1-01, UCIRVINE-2006-4937, NCT00462280


2.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Treatment
Active
18 and over
Other
200104050
NCT00583102


3.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II, Phase I
Treatment
Active
19 to 90
Other
200311038
NCT00584012


4.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Biomarker/Laboratory analysis, Diagnostic, Prevention
Active
18 to 70
Other
BRSNSTU0010
NCT00285857


5.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Supportive care
Active
18 and over
Other
MCC-10802
NCT00580970


6.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase II
Treatment
Active
18 and over
Other
200305074
NCT00585052


7.
Phase
 Type
 Status
 Age
 Sponsor
 Protocol IDs

Phase I
Supportive care
Active
18 to 45
Other
05-08-069-01
NCT00352599

   
  Display for Print   New Search

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov